| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-12 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.26 | 9e-10 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |